Performance of two SARS-CoV-2 rapid antigen detection tests in resource limited settings, the case of Mali.
Humans
Mali
/ epidemiology
COVID-19
/ diagnosis
Cross-Sectional Studies
Sensitivity and Specificity
SARS-CoV-2
/ isolation & purification
COVID-19 Serological Testing
/ methods
Antigens, Viral
/ analysis
Female
Male
Adult
COVID-19 Nucleic Acid Testing
/ methods
Prevalence
Real-Time Polymerase Chain Reaction
COVID-19 Testing
/ methods
Resource-Limited Settings
SARS-CoV-2
performance
rapid antigen tests
Journal
African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
8
7
2024
Statut:
ppublish
Résumé
While real-time reverse transcription PCR (RT-PCR) is the recommended laboratory method to diagnose severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection, its use in resource limited settings can be difficult to maintain due to high testing demand and shortage of reagents. The aim of this study was to evaluate the performances of Realy Tech™ and Standard Q™ in comparison to RT-PCR in a relatively low COVID-19 prevalence setting, Mali. We conducted a cross-sectional study between January and April 2021 in Bamako and Kati regions to evaluate both rapid tests during a large SARS-CoV-2 prevalence study in Mali. Of the 390 samples tested, the sensitivity and specificity of Realy Tech™ and Standard Q™ were 57.1% (95%CI: 44.1-69.2), 95.8% (95%CI: 93.1-97.5); 61.9% (95%CI: 46.8-75.0), and 94.1% (95%CI: 89.5-96.8) respectively. Using RT-PCR, the global prevalence of SARS-CoV-2 was 14.4% (56/390). In both rapid antigen tests, the performance was better when used in suspected patients compared to positive patients under treatment. Moreover, higher viral loads equivalent to Ct < 25 were associated with better detection rates. While waiting for more complete data, these preliminary studies suggest that Realy Tech™ and Standard Q™ should not be used alone for COVID-19 diagnosis in Mali.
Identifiants
pubmed: 38974252
doi: 10.4314/ahs.v23i4.15
pii: jAFHS.v23.i4.pg122
pmc: PMC11225473
doi:
Substances chimiques
Antigens, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122-131Informations de copyright
© 2023 Fatimata D et al.
Déclaration de conflit d'intérêts
The funding sources of this study had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors reported no conflicts.